Frequent p16(INK4) (MTS1) gene inactivation in testicular germ cell tumors

American Journal of Pathology

Volumn 151, Issue 3, 1997, Pages 859-865

  Chaubert, Pascal ^a   Guillou, Louis ^a   Kurt, Anne Marie ^c   Bertholet, Marie Martine ^a   Metthez, Geneviève ^a   Leisinger, Hans Jürg ^b   Bosman, Fred ^a   Shaw, Phil ^a  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Institut universitaire de Pathologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P16; CARRIER PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN P14ARF; PROTEIN P16INK4A;

ADOLESCENT; ADULT; ARTICLE; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; DNA METHYLATION; DNA SEQUENCE; EXON; GENE EXPRESSION; GERM CELL TUMOR; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINOMA; CHROMOSOME DELETION; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; METABOLISM; MIDDLE AGED; NEOPLASM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM; TESTIS TUMOR; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; BASE SEQUENCE; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS; RNA, MESSENGER; TESTICULAR NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0030611614     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach D, Depinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996, 85:27-37
2. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-707
3. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994, 264:436-440
4. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994, 368:753-756
5. Schmidt EE, Ichimura K, Reifenberger G, Collins VP: CDKN2 (p16/ MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994, 54:6321-6324
6. Herbert J, Cayuela JM, Berkeley J, Sigaux F: Candidate tumor-suppressor genes MTS1 (p16 INK4A) and MTS2 (p15 INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias. Blood 1994, 84:4038-4044
7. Spruck CH, Gonzalez-Zulueta M, Shibata A, Simoneau AR, Lin MF, Gonzales F, Tsai YC, Jones PA: p16 gene in uncultured tumours. Nature 1994, 370:183-184
8. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B: Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994, 54:6353-6358
9. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH, Tucker MA, Dracopoli NC: Germline p16 mutations in familial melanoma. Nature Genet 1994, 8:15-21
10. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 1994, 8:27-32
11. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y: Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/ cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 1994, 54:3396-3397
12. Zhou X, Tarmin L, Yin J, Jiang HY, Suzuki H, Rhyu MG, Abraham JM, Meltzer SJ: The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene 1994, 9: 3737-3741
13. Giani C, Finocchiaro G: Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res 1994, 54:6338-6339
14. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1995, 1:686-692
15. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA: Methylation of the 5′ CpG island of the p16/ CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995, 55:4531-4535
16. Herman JG, Merlo A, Mao Li, Lapidus RG, Issa JPJ, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995, 55:4525-4530
17. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A: Complex structure and regulation of the p16 (MTS1) locus. Cancer Res 1995, 55:2988-2994
18. Quelle DE, Zindy F, Ashmun RA, Sherr CJ: Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995, 83:993-1000
19. INK4A transcript. Cancer Res 1995, 55:2995-2997
20. Cordon-Cardo C: Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1995, 147:545-560
21. Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde KH, Beach D: A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995, 269:1281-1284
22. Guillou L, Estreicher A, Chaubert P, Hurlimann J, Kurt AM, Metthez G, Iggo R, Jichlinski P, Leisinger HJ, Benhattar J: Germ cell tumors of the testis overexpress wild-type p53. Am J Pathol 1996, 149:1221-1228
23. Hatta Y, Hirama T, Takeuchi S, Lee E, Pham E, Miller CW, Strohmeyer T, Wilczynski SP, Melmed S, Koeffler HP: Alterations of the p16 (MTS1) gene in testicular, ovarian, and endometrial malignancies. J Urol 1995, 154:1954-1957
24. Chaubert P, Bautista D, Benhattar J: An improved method for rapid screening of DNA mutations by nonradioactive single-strand conformation polymorphism procedure. Biotechniques 1993, 15:586
25. ink4(MTS1) gene. Mol Cell Probes 1996, 10:467-468
26. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D, Sidransky D: Frequency of homozygous deletion at p16/ CDKN2 in primary human tumours. Nature Genet 1995, 11:210-212
27. Peng HQ, Bailey D, Bronson D, Goss PE, Hogg D: Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res 1995, 55:2871-2875
28. Lothe RA, Peltomaki P, Tommerup N, Fossa SD, Stenwig AE, Borresen AL, Nesland JM: Molecular genetic changes in human male germ cell tumors. Lab Invest 1995, 73:606-614
29. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y: Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 1994, 8:2939-2952
30. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J: Retinoblastoma-protein dependent cell-cycle inhibition by the tumour suppressor p16. Nature 1995, 375:503-506
31. Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. Int J Cancer 1995, 61:115-120
32. Strohmeyer T, Reissmann P, Cordon-Cardo C, Hartmann M, Ackermann R, Slamon D: Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci USA 1991, 88:6662-6666
33. Peng HQ, Bailey D, Bronson D, Goss PE, Hogg D: Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res 1995, 55:2871-2875